TTrialPathMatch Me to Trials
← Back to trials
RecruitingObesity or OverweightCardiovascular Disease

A Phase III Study to Evaluate the Efficacy and Safety of Petrelintide in Participants With Overweight or Obesity and Established Cardiovascular Disease

Eligible age

40+ yrs

Accepts

All genders

Locations

4 states

Healthy volunteers

No

See if you qualify for this study

Answer a few quick questions about your location and health. Takes about a minute.

Check my eligibility →

About this study

This study will evaluate the efficacy and safety of petrelintide compared with placebo, in conjunction with a reduced-calorie diet and increased physical activity, for weight management in participants living with overweight or obesity and established cardiovascular disease (CVD).

Sponsor: Hoffmann-La Roche

You may qualify if…

  • ✓ Participants with BMI ≥ 27 kg/m² and established CVD
  • ✓ History of at least one self-reported unsuccessful dietary effort to lose body weight

You may not qualify if…

  • ✕ Known history of Type 1 diabetes mellitus
  • ✕ Current or previous treatment with petrelintide or any other amylin analog

Where it's recruiting

Alabama

Anniston

California

Los Angeles · San Carlos

Florida

Boynton Beach · Port Orange

Indiana

Indianapolis

Source: ClinicalTrials.gov · NCT07843472 · last updated 2026-11-16

A Phase III Study to Evaluate the Efficacy and Safety of Petrelintide · TrialPath